Fig. 4. Survival charts considering diameter and chemotherapy. Overall survival (OS) of patients with ablated tumors less than 3 cm (A) and 3–5 cm (B). Liver progression-free survival (Li-PFS) of patients with ablated tumors less than 3 cm (C) and 3–5 cm (D). CI, confidence interval; NA, not applicable.

Int J Gastrointest Interv 2023;12:130~139 https://doi.org/10.18528/ijgii230019

© Int J Gastrointest Interv